Brief: Sinomab Bioscience Says Fang Liang Resigns As Executive Director
18/08/2026 15:48
BRIEF-Sinomab Bioscience Says Fang Liang Resigns As Executive Director Aug 18 (Reuters) - SinoMab BioScience Ltd 3681.HK:
FANG LIANG RESIGNS AS EXECUTIVE DIRECTOR AND COO EFFECTIVE 18 AUGUST 2026
Further company coverage: 3681.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sinomab Bioscience
See all newsBrief: Sinomab Bioscience Posts HY Loss Of RMB127.4 Million
Brief: Sinomab Bioscience Says Fang Liang Resigns As Executive Director
Brief: Sinomab Bioscience Announces Major Deal For Disposal Of Suzhou Property And Facility For RMB280 MLN
Brief: SinoMab Bioscience Appoints Fang Liang As Executive Director
Brief: Hainan Haiyao Plans To Unload Stake In Sinomab Bioscience